David Levine

Variations in your cognitive performance before exposure to a respiratory virus can predict the severity of the infection.

Some studies show it’s better than SSRIs—but there’s no incentive to invest in clinical trials.

Targeting a key molecule that helps the brain process sensory threats could lead to new treatments for PTSD, migraines, and autism.

Resuscitation expert Sam Parnia studies near death experiences—and how your brain can give you access to new dimensions of reality.

A new study questions whether depression is really caused by a chemical imbalance.

New software to catch signs of cognitive decline earlier could help reduce the risk of dementia.

Digital tools, early detection, and better insurance policies can address the coming wave of cognitive decline.

Alto Neuroscience wants to use EEG brain biomarkers to better match the right treatment to a person’s needs.

Hallucinations are a surprisingly common symptom of Parkinson’s, and new research suggests a way to map and potentially treat them.